Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Healthpeak Properties Inc has a consensus price target of $20.27 based on the ratings of 24 analysts. The high is $25 issued by Argus Research on April 29, 2025. The low is $14 issued by Truist Securities on December 22, 2023. The 3 most-recent analyst ratings were released by Morgan Stanley, Wells Fargo, and Scotiabank on June 11, 2026, June 1, 2026, and May 27, 2026, respectively. With an average price target of $21 between Morgan Stanley, Wells Fargo, and Scotiabank, there's an implied 1.06% upside for Healthpeak Properties Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Healthpeak Properties (NYSE:DOC) was reported by Morgan Stanley on June 11, 2026. The analyst firm set a price target for $22.00 expecting DOC to rise to within 12 months (a possible 5.87% upside). 27 analyst firms have reported ratings in the last year.
The latest analyst rating for Healthpeak Properties (NYSE:DOC) was provided by Morgan Stanley, and Healthpeak Properties downgraded their equal-weight rating.
The last upgrade for Healthpeak Properties Inc happened on September 15, 2025 when Raymond James raised their price target to $20. Raymond James previously had a market perform for Healthpeak Properties Inc.
The last downgrade for Healthpeak Properties Inc happened on June 11, 2026 when Morgan Stanley changed their price target from $20 to $22 for Healthpeak Properties Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Healthpeak Properties, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Healthpeak Properties was filed on June 11, 2026 so you should expect the next rating to be made available sometime around June 11, 2027.
While ratings are subjective and will change, the latest Healthpeak Properties (DOC) rating was a downgraded with a price target of $20.00 to $22.00. The current price Healthpeak Properties (DOC) is trading at is $20.78, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Buy Now | Get Alert | ||||||
|---|---|---|---|---|---|---|---|
| 06/11/2026 | Buy Now | 5.87% | Morgan Stanley | $20 → $22 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 06/01/2026 | Buy Now | -3.75% | Wells Fargo | $18 → $20 | Maintains | Equal-Weight | Get Alert |
| 05/27/2026 | Buy Now | 1.06% | Scotiabank | $19 → $21 | Maintains | Sector Perform | Get Alert |
| 05/22/2026 | Buy Now | -3.75% | Morgan Stanley | $18 → $20 | Maintains | Overweight | Get Alert |
| 05/14/2026 | Buy Now | 1.06% | RBC Capital | $20 → $21 | Maintains | Outperform | Get Alert |
| 05/13/2026 | Buy Now | -8.57% | UBS | $17 → $19 | Maintains | Neutral | Get Alert |
| 05/13/2026 | Buy Now | 1.06% | Baird | $19 → $21 | Maintains | Outperform | Get Alert |
| 05/12/2026 | Buy Now | -3.75% | Citigroup | $17.5 → $20 | Maintains | Neutral | Get Alert |
| 04/28/2026 | Buy Now | -13.38% | Morgan Stanley | $21 → $18 | Maintains | Overweight | Get Alert |
| 04/20/2026 | Buy Now | -18.19% | UBS | → $17 | Initiates | → Neutral | Get Alert |
| 04/06/2026 | Buy Now | -8.57% | Baird | $20 → $19 | Maintains | Outperform | Get Alert |
| 04/01/2026 | Buy Now | -15.78% | Citigroup | $18 → $17.5 | Maintains | Neutral | Get Alert |
| 02/05/2026 | Buy Now | — | Argus Research | — | Downgrade | Buy → Hold | Get Alert |
| 02/04/2026 | Buy Now | -8.57% | Evercore ISI Group | $21 → $19 | Maintains | Outperform | Get Alert |
| 02/02/2026 | Buy Now | -13.38% | Wells Fargo | $19 → $18 | Maintains | Equal-Weight | Get Alert |
| 01/09/2026 | Buy Now | -18.19% | Goldman Sachs | → $17 | Initiates | → Neutral | Get Alert |
| 12/16/2025 | Buy Now | -18.19% | Jefferies | $21 → $17 | Downgrade | Buy → Hold | Get Alert |
| 12/15/2025 | Buy Now | 1.06% | Evercore ISI Group | $22 → $21 | Maintains | Outperform | Get Alert |
| 11/25/2025 | Buy Now | -8.57% | Wells Fargo | $18 → $19 | Maintains | Equal-Weight | Get Alert |
| 11/12/2025 | Buy Now | -3.75% | Baird | $21 → $20 | Maintains | Outperform | Get Alert |
| 10/01/2025 | Buy Now | -3.75% | Cantor Fitzgerald | → $20 | Initiates | → Neutral | Get Alert |
| 09/15/2025 | Buy Now | -3.75% | Raymond James | → $20 | Upgrade | Market Perform → Outperform | Get Alert |
| 08/27/2025 | Buy Now | -13.38% | Wells Fargo | $20 → $18 | Maintains | Equal-Weight | Get Alert |
| 08/22/2025 | Buy Now | 1.06% | Morgan Stanley | $22 → $21 | Maintains | Overweight | Get Alert |
| 08/20/2025 | Buy Now | -13.38% | Deutsche Bank | $28 → $18 | Downgrade | Buy → Hold | Get Alert |
| 07/30/2025 | Buy Now | 1.06% | Baird | $22 → $21 | Maintains | Outperform | Get Alert |
| 07/29/2025 | Buy Now | -8.57% | Scotiabank | $21 → $19 | Downgrade | Sector Outperform → Sector Perform | Get Alert |
| 06/02/2025 | Buy Now | -3.75% | Wells Fargo | $22 → $20 | Maintains | Equal-Weight | Get Alert |
| 05/12/2025 | Buy Now | 1.06% | Scotiabank | $23 → $21 | Maintains | Sector Outperform | Get Alert |
| 04/29/2025 | Buy Now | 20.31% | Argus Research | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 04/29/2025 | Buy Now | 5.87% | Baird | $24 → $22 | Maintains | Outperform | Get Alert |
| 04/28/2025 | Buy Now | 1.06% | Evercore ISI Group | $23 → $21 | Maintains | Outperform | Get Alert |
| 04/28/2025 | Buy Now | 5.87% | Wedbush | $24 → $22 | Maintains | Outperform | Get Alert |
| 04/11/2025 | Buy Now | 15.5% | Wedbush | $24 → $24 | Reiterates | Outperform → Outperform | Get Alert |
| 02/28/2025 | Buy Now | 10.68% | Scotiabank | $24 → $23 | Maintains | Sector Outperform | Get Alert |
| 02/14/2025 | Buy Now | 15.5% | Wedbush | $27 → $24 | Maintains | Outperform | Get Alert |
| 02/11/2025 | Buy Now | 15.5% | Baird | $25 → $24 | Maintains | Outperform | Get Alert |
| 12/10/2024 | Buy Now | 5.87% | Wells Fargo | $23 → $22 | Maintains | Equal-Weight | Get Alert |
| 12/05/2024 | Buy Now | 15.5% | Mizuho | $25 → $24 | Maintains | Outperform | Get Alert |
| 11/04/2024 | Buy Now | 25.12% | RBC Capital | $25 → $26 | Maintains | Outperform | Get Alert |
| 10/30/2024 | Buy Now | 20.31% | Baird | $24 → $25 | Maintains | Outperform | Get Alert |
| 10/21/2024 | Buy Now | 34.74% | Deutsche Bank | $20 → $28 | Upgrade | Hold → Buy | Get Alert |
| 10/01/2024 | Buy Now | 10.68% | Wells Fargo | $22 → $23 | Assumes | Equal-Weight → Equal-Weight | Get Alert |
| 09/16/2024 | Buy Now | 25.12% | Evercore ISI Group | $25 → $26 | Maintains | Outperform | Get Alert |
| 09/09/2024 | Buy Now | 15.5% | Scotiabank | $23 → $24 | Maintains | Sector Outperform | Get Alert |
| 08/28/2024 | Buy Now | 20.31% | Evercore ISI Group | $24 → $25 | Maintains | Outperform | Get Alert |
| 08/22/2024 | Buy Now | 5.87% | Citigroup | $20 → $22 | Maintains | Neutral | Get Alert |
| 07/30/2024 | Buy Now | 20.31% | RBC Capital | $22 → $25 | Maintains | Outperform | Get Alert |
| 07/29/2024 | Buy Now | 20.31% | Wedbush | $22 → $25 | Maintains | Outperform | Get Alert |
| 05/16/2024 | Buy Now | 10.68% | Scotiabank | $22 → $23 | Maintains | Sector Outperform | Get Alert |
| 05/16/2024 | Buy Now | 1.06% | JP Morgan | $19 → $21 | Maintains | Neutral | Get Alert |
| 05/03/2024 | Buy Now | — | Wedbush | — | Upgrade | Neutral → Outperform | Get Alert |
| 04/22/2024 | Buy Now | 5.87% | Mizuho | → $22 | Reinstates | → Buy | Get Alert |
| 04/10/2024 | Buy Now | 5.87% | RBC Capital | $21 → $22 | Maintains | Outperform | Get Alert |
| 04/01/2024 | Buy Now | 20.31% | B of A Securities | $18 → $25 | Upgrade | Underperform → Buy | Get Alert |
| 03/25/2024 | Buy Now | -8.57% | Wells Fargo | → $19 | Reinstates | → Equal-Weight | Get Alert |
| 03/08/2024 | Buy Now | 1.06% | RBC Capital | → $21 | Reinstates | → Outperform | Get Alert |
| 01/05/2024 | Buy Now | — | Keybanc | — | Downgrade | Overweight → Sector Weight | Get Alert |
| 01/02/2024 | Buy Now | -13.38% | Compass Point | $19 → $18 | Maintains | Buy | Get Alert |
| 12/22/2023 | Buy Now | -32.63% | Truist Securities | $15 → $14 | Maintains | Hold | Get Alert |
| 08/22/2023 | Buy Now | -32.63% | Citigroup | $15 → $14 | Maintains | Neutral | Get Alert |
| 08/16/2023 | Buy Now | -27.82% | Truist Securities | → $15 | Reiterates | Hold → Hold | Get Alert |
| 08/07/2023 | Buy Now | -27.82% | Wells Fargo | $14 → $15 | Maintains | Underweight | Get Alert |
| 07/20/2023 | Buy Now | -30.22% | Morgan Stanley | $14.5 → $14.5 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |